Centocor/Lilly’s Reopro Phase III Ischemic Stroke Study Suspended
This article was originally published in The Pink Sheet Daily
Executive Summary
Enrollment in the Abciximab in Emergent Stroke Treatment Trial-II was halted due to concerns about the rate of intracranial hemorrhage.